Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Respiratory Therapy, Chang-Gung University College of Medicine, Taoyuan, Taiwan.
J Formos Med Assoc. 2022 Jun;121(6):1149-1158. doi: 10.1016/j.jfma.2021.10.007. Epub 2021 Oct 16.
BACKGROUND/PURPOSE: Both prone positioning and extracorporeal membrane oxygenation (ECMO) are used as rescue therapies for severe hypoxemia in patients with acute respiratory distress syndrome (ARDS). This study compared outcomes between patients with severe influenza pneumonia-related ARDS who received prone positioning and those who received ECMO.
This retrospective cohort study included eight tertiary referral centers in Taiwan. All patients who were diagnosed as having influenza pneumonia-related severe ARDS were enrolled between January and March 2016. We collected their demographic data and prone positioning and ECMO outcomes from medical records.
In total, 263 patients diagnosed as having ARDS were included, and 65 and 53 of them received prone positioning and ECMO, respectively. The baseline PaO/FiO ratio, Acute Physiology and Chronic Health Evaluation II score and Sequential Organ Failure Assessment score did not significantly differ between the two groups. The 60-day mortality rate was significantly higher in the ECMO group than in the prone positioning group (60% vs. 28%, p = 0.001). A significantly higher mortality rate was still observed in the ECMO group after propensity score matching (59% vs. 36%, p = 0.033). In the multivariate Cox regression analysis, usage of prone positioning or ECMO was the single independent predictor for 60-day mortality (hazard ratio: 2.177, p = 0.034).
While the patients receiving prone positioning had better outcome, the causality between prone positioning and the prognosis is unknown. However, the current data suggested that patients with influenza-related ARDS may receive prone positioning before ECMO support.
背景/目的:俯卧位通气和体外膜肺氧合(ECMO)均被用于治疗急性呼吸窘迫综合征(ARDS)患者的严重低氧血症。本研究比较了接受俯卧位通气和 ECMO 治疗的严重流感相关 ARDS 患者的结局。
这是一项回顾性队列研究,纳入了台湾的 8 家三级转诊中心。所有于 2016 年 1 月至 3 月间被诊断为流感相关严重 ARDS 的患者均被纳入本研究。我们从病历中收集了患者的人口统计学数据以及俯卧位通气和 ECMO 的相关结局。
共有 263 名被诊断为 ARDS 的患者被纳入本研究,其中 65 名和 53 名患者分别接受了俯卧位通气和 ECMO 治疗。两组患者的基线 PaO/FiO 比值、急性生理学与慢性健康状况评分系统 II 评分和序贯器官衰竭评估评分均无显著差异。ECMO 组的 60 天死亡率显著高于俯卧位通气组(60% vs. 28%,p=0.001)。即使在进行倾向评分匹配后,ECMO 组的死亡率仍显著更高(59% vs. 36%,p=0.033)。在多变量 Cox 回归分析中,使用俯卧位通气或 ECMO 是 60 天死亡率的独立预测因素(风险比:2.177,p=0.034)。
尽管接受俯卧位通气的患者有更好的结局,但俯卧位通气与预后之间的因果关系尚不清楚。然而,目前的数据表明,流感相关 ARDS 患者可能在接受 ECMO 支持之前接受俯卧位通气。